Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: aleurain; Cat H; Cat K; Cathepsin B3; Cathepsin BA; Cathepsin H; Cathepsin H heavy chain; Cathepsin H light chain; Cathepsin H mini chain; Cathepsin K; Cathepsin L2; cathepsin L2, preproprotein; Cathepsin O; cathepsin O1; Cathepsin O2; Cathepsin U; Cathepsin V; Cathepsin X; minisatellite 10q detected by probe MMS10; N-benzoylarginine-beta-naphthylamide hydrolase; p21-Rac3; Pro-cathepsin H; Ras-related C3 botulinum toxin substrate 3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3); rho family, small GTP binding protein Rac3
Gene Aliases: ACC-4; ACC-5; ACC4; ACC5; AI323530; AL022844; catK; CATL2; CPSB; CTS02; CTSH; CTSK; CTSL2; CTSO; CTSO1; CTSO2; CTSU; CTSV; MMS10-Q; Ms10q; PKND; PYCD; Rac1B; RAC3; UNQ268/PRO305